The Market Signal was created as a platform to help investors, if you own (NYSE:FME), (NYSE:DGX) or (NYSE:GFI) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.
https://themarketsignal.com/Free-Report/NOW
(Click link above or copy, paste and hit enter in your browser for your report)
Fresenius Medical Care remains stable even during the COVID-19 outbreak
https://themarketsignal.com/Free-Report/FME
(Click link above or copy, paste and hit enter in your browser for your report)
The forward P/E of Fresenius Medical Care AG & Co (NYSE:FME) stands at 11.21, a figure that is lower than its current P/E of 11.44. This performance points out to brighter days ahead where the company may be witnessing an increase in earnings.
The company stands out as one of the biggest providers dealing in the sale of dialysis products and services. It has indicated great stability even during the COVID-19 outbreak and its growth curve remains impressive. That is according to the company's Chief Executive Officer Rice Powell.
Shareholder majorities of 96.60 and 94.58 percent, respectively, approved the actions of the General Partner and the Supervisory Board in 2019.
Powel spoke out on the company's Global Sustainability Program and its focus. It was a program started a year ago and Powel will be overseeing its activities. The compensation of the Management Board members will in future be addressed through the new program.
The 23rd consecutive dividend increase is a position that many members agree on, and that is considering the 99.89 percent that voted in its favor. The dividend will stand at EUR1.20 per share following the v increase.
Quest Diagnostics supports efforts to address disparities in health
https://themarketsignal.com/Free-Report/DGX
(Click link above or copy, paste and hit enter in your browser for your report)
The 12.40 forward P/E of Quest Diagnostics Inc (NYSE:DGX) is lower than a figure of 20.13 which is the current P/E. This change shows that the earnings might rise in future.
It was today that Quest Diagnostics Foundation and Quest Diagnostics spoke in relation to the advancement of a new initiative targeting addressing and reducing health disparities. That is a program targeting mostly those affected adversely by the outbreak of the COVID-19 pandemic. It is a multi-year initiative working elaborately in the delivery of financial support, education programs, donated testing services and partnerships.
The groups being targeted by the initiative include people of color, homeless populations and the elderly. The partnership between the company and the Quest Foundation is for long term projects such as the establishment of schools, care facilities, universities and community organizations.
- The goals of the initiatives include:
- Give a boost to COVID-19 testing programs
- Focusing on the social determinants of health and addressing challenges
- Promote education and awareness in line with better diagnostic and testing
Gold Fields looks forward to brighter days ahead
https://themarketsignal.com/Free-Report/GFI
(Click link above or copy, paste and hit enter in your browser for your report)
Gold Fields Limited (NYSE:GFI) has a forward P/E of 11.79 which is way below its current P/E of 46.49indicating that the earnings of the company are expected to increase in future.
Please email or contact us for any edits or errors relating to this stock market news.
If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.
We will get back to you within 24 hours.
COMTEX_370546188/2700/2020-09-02T06:18:23
Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.
